IL316892A - Multispecific proprotein binding molecules and their uses - Google Patents

Multispecific proprotein binding molecules and their uses

Info

Publication number
IL316892A
IL316892A IL316892A IL31689224A IL316892A IL 316892 A IL316892 A IL 316892A IL 316892 A IL316892 A IL 316892A IL 31689224 A IL31689224 A IL 31689224A IL 316892 A IL316892 A IL 316892A
Authority
IL
Israel
Prior art keywords
proproteins
binding molecule
multispecific binding
multispecific
molecule
Prior art date
Application number
IL316892A
Other languages
English (en)
Hebrew (he)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL316892A publication Critical patent/IL316892A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL316892A 2022-05-11 2023-05-10 Multispecific proprotein binding molecules and their uses IL316892A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263340891P 2022-05-11 2022-05-11
US202363481291P 2023-01-24 2023-01-24
US202363489812P 2023-03-13 2023-03-13
PCT/US2023/066841 WO2023220647A1 (en) 2022-05-11 2023-05-10 Multispecific binding molecule proproteins and uses thereof

Publications (1)

Publication Number Publication Date
IL316892A true IL316892A (en) 2025-01-01

Family

ID=86760424

Family Applications (1)

Application Number Title Priority Date Filing Date
IL316892A IL316892A (en) 2022-05-11 2023-05-10 Multispecific proprotein binding molecules and their uses

Country Status (9)

Country Link
US (1) US20250340668A1 (OSRAM)
EP (1) EP4522649A1 (OSRAM)
JP (1) JP2025516596A (OSRAM)
KR (1) KR20250024872A (OSRAM)
CN (1) CN119546628A (OSRAM)
AU (1) AU2023269792A1 (OSRAM)
CA (1) CA3252786A1 (OSRAM)
IL (1) IL316892A (OSRAM)
WO (1) WO2023220647A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4735043A1 (en) * 2023-06-30 2026-05-06 The Regents of the University of California Pro-polypeptides and methods of using and designing the same
US20250297006A1 (en) * 2024-03-20 2025-09-25 Regeneron Pharmaceuticals, Inc. Masked Multispecific Antigen-Binding Molecules with Cleavable Linkers

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677425A (en) 1987-09-04 1997-10-14 Celltech Therapeutics Limited Recombinant antibody
US5582996A (en) 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
US5932448A (en) 1991-11-29 1999-08-03 Protein Design Labs., Inc. Bispecific antibody heterodimers
ES2102007T3 (es) 1992-01-23 1997-07-16 Merck Patent Gmbh Proteinas de fusion de fragmentos de anticuerpo monomeras y dimeras.
PT1621554E (pt) 1992-08-21 2009-07-13 Univ Bruxelles Imunoglobtainas desprovidas de cadeias leves
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
GB9720054D0 (en) 1997-09-19 1997-11-19 Celltech Therapeutics Ltd Biological products
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
HUE026278T2 (en) 2003-07-01 2016-05-30 Ucb Biopharma Sprl Modified Fab antibody fragments
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
CA2577082A1 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
CN101198698B (zh) 2005-03-31 2014-03-19 中外制药株式会社 通过调节多肽缔合制备多肽的方法
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
EP3663318A1 (en) 2008-01-07 2020-06-10 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
LT2975051T (lt) 2009-06-26 2021-07-12 Regeneron Pharmaceuticals, Inc. Lengvai išskiriami bispecifiniai antikūnai su natyvios formos imunoglobulinu
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
EP2611834B1 (en) 2010-09-01 2018-03-07 Biogen MA Inc. Rapid generation of anti-idiotypic antibodies
MX385344B (es) 2012-11-28 2025-03-18 Zymeworks Bc Inc Pares de cadena pesada-cadena ligera de inmunoglobulina modificados genéticamente y usos de estos.
TWI682941B (zh) 2013-02-01 2020-01-21 美商再生元醫藥公司 含嵌合恆定區之抗體
ES2821753T3 (es) 2013-03-15 2021-04-27 Lilly Co Eli Procedimientos de producción de Fab y de anticuerpos biespecíficos
TWI681969B (zh) 2014-01-23 2020-01-11 美商再生元醫藥公司 針對ｐｄ-１的人類抗體
WO2016161010A2 (en) 2015-03-30 2016-10-06 Regeneron Pharmaceuticals, Inc. Heavy chain constant regions with reduced binding to fc gamma receptors
AU2016333517B2 (en) 2015-10-02 2023-09-07 Les Laboratoires Servier Anti-PD-1 antibodies and compositions
ES3034233T3 (en) 2016-01-22 2025-08-14 MabQuest SA Non-blocking pd1 specific antibodies
MA43724B1 (fr) 2016-03-22 2023-06-28 Hoffmann La Roche Molécules bispécifiques de cellules t activées par une protéase
US11390676B2 (en) 2016-10-13 2022-07-19 Symphogen A/S Anti-LAG-3 antibodies and compositions

Also Published As

Publication number Publication date
CN119546628A (zh) 2025-02-28
CA3252786A1 (en) 2023-11-16
US20250340668A1 (en) 2025-11-06
EP4522649A1 (en) 2025-03-19
AU2023269792A1 (en) 2024-11-28
WO2023220647A1 (en) 2023-11-16
JP2025516596A (ja) 2025-05-30
KR20250024872A (ko) 2025-02-19

Similar Documents

Publication Publication Date Title
IL315265A (en) Multiple antibodies and their uses
IL289415A (en) Claudin-6 binding molecules and their use
IL288314A (en) Anti-tdp-43 binding molecules and uses thereof
GB202006629D0 (en) Specific binding molecules
IL312184A (en) DNA compositions and related methods
IL304485A (en) Anti-cd123 binding compounds and their uses
ZA202210020B (en) Cd137 binding molecules and uses thereof
IL283087B1 (en) Multispecific binding constructs against checkpoint compounds and their uses
IL319125A (en) DLL3 binding molecules and their uses
IL306082A (en) TROP2 binding antibodies and their uses
AU2021411652A9 (en) Mesothelin binding molecule and application thereof
GB2426974B (en) RDX composition and process
GB202010329D0 (en) Specific binding molecules
GB202306345D0 (en) Binding molecules
IL316176A (en) SIGLEC-8 binding proteins and their uses
GB202009930D0 (en) Tau epitodes and binding molecules
IL315541A (en) Multispecific antibodies and their uses
IL315540A (en) Multispecific antibodies and their uses
IL319680A (en) Multispecific proteins and related methods
HK40120069A (en) Multispecific binding agents and uses thereof
AU2003201559A8 (en) Multispecific binding molecules
IL327199A (en) Multispecific antibodies and their uses
IL325822A (en) Multispecific antibodies and their uses
IL315544A (en) Multispecific antibodies and their uses
HK40112976A (en) Ror1-targeted binding molecule and use thereof